S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Rare Earth Elements: The Workhorse of The Tech Revolution (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
US economy grew solid 3.2% in fourth quarter, a slight downgrade from government's initial estimate
Rare Earth Elements: The Workhorse of The Tech Revolution (Ad)
Dubai's sky-high aspirations find a new outlet as it hosts a jet suit race for 'Iron Man' pilots
Apple Cancels Its 10-Year Electric Car Project, Moves Some Employees to AI Division
Rare Earth Elements: The Workhorse of The Tech Revolution (Ad)
Leaders, Here Are 4 Ways You're Inadvertently Destroying Trust in the Workplace (and What to Do Instead)
Wendy's says it has no plans to raise prices during the busiest times at its restaurants
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Rare Earth Elements: The Workhorse of The Tech Revolution (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
US economy grew solid 3.2% in fourth quarter, a slight downgrade from government's initial estimate
Rare Earth Elements: The Workhorse of The Tech Revolution (Ad)
Dubai's sky-high aspirations find a new outlet as it hosts a jet suit race for 'Iron Man' pilots
Apple Cancels Its 10-Year Electric Car Project, Moves Some Employees to AI Division
Rare Earth Elements: The Workhorse of The Tech Revolution (Ad)
Leaders, Here Are 4 Ways You're Inadvertently Destroying Trust in the Workplace (and What to Do Instead)
Wendy's says it has no plans to raise prices during the busiest times at its restaurants
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Rare Earth Elements: The Workhorse of The Tech Revolution (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
US economy grew solid 3.2% in fourth quarter, a slight downgrade from government's initial estimate
Rare Earth Elements: The Workhorse of The Tech Revolution (Ad)
Dubai's sky-high aspirations find a new outlet as it hosts a jet suit race for 'Iron Man' pilots
Apple Cancels Its 10-Year Electric Car Project, Moves Some Employees to AI Division
Rare Earth Elements: The Workhorse of The Tech Revolution (Ad)
Leaders, Here Are 4 Ways You're Inadvertently Destroying Trust in the Workplace (and What to Do Instead)
Wendy's says it has no plans to raise prices during the busiest times at its restaurants
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Rare Earth Elements: The Workhorse of The Tech Revolution (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
US economy grew solid 3.2% in fourth quarter, a slight downgrade from government's initial estimate
Rare Earth Elements: The Workhorse of The Tech Revolution (Ad)
Dubai's sky-high aspirations find a new outlet as it hosts a jet suit race for 'Iron Man' pilots
Apple Cancels Its 10-Year Electric Car Project, Moves Some Employees to AI Division
Rare Earth Elements: The Workhorse of The Tech Revolution (Ad)
Leaders, Here Are 4 Ways You're Inadvertently Destroying Trust in the Workplace (and What to Do Instead)
Wendy's says it has no plans to raise prices during the busiest times at its restaurants

Adicet Bio (ACET) Stock Forecast & Price Target

$2.33
-0.06 (-2.51%)
(As of 02/28/2024 ET)

Adicet Bio Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 7 Analyst Ratings

Analysts' Consensus Price Target

$14.50
522.32% Upside
High Forecast$27.00
Average Forecast$14.50
Low Forecast$6.00
TypeCurrent Forecast
3/1/23 to 2/29/24
1 Month Ago
1/30/23 to 1/30/24
3 Months Ago
12/1/22 to 12/1/23
1 Year Ago
3/1/22 to 3/1/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
6 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$14.50$15.50$15.50$27.71
Predicted Upside522.32% Upside376.26% Upside401.03% Upside81.28% Upside
Get Adicet Bio Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ACET and its competitors with MarketBeat's FREE daily newsletter.


ACET Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ACET Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Adicet Bio Stock vs. The Competition

TypeAdicet BioMedical CompaniesS&P 500
Consensus Rating Score
2.57
2.68
2.48
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside522.32% Upside1,853.88% Upside7.87% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/5/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform$15.00+380.77%
2/2/2024HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$26.00 ➝ $10.00+231.13%
9/6/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$27.00+1,383.51%
8/10/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$20.00 ➝ $10.00+321.94%
6/27/2023Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
6/27/2023JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reni Benjamin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
6/1/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Neutral$20.00 ➝ $6.00+9.49%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:33 AM ET.












ACET Price Target - Frequently Asked Questions

What is Adicet Bio's consensus rating and price target?

According to the issued ratings of 7 analysts in the last year, the consensus rating for Adicet Bio stock is Moderate Buy based on the current 3 hold ratings and 4 buy ratings for ACET. The average twelve-month price prediction for Adicet Bio is $14.50 with a high price target of $27.00 and a low price target of $6.00. Learn more on ACET's analyst rating history.

Do Wall Street analysts like Adicet Bio more than its competitors?

Analysts like Adicet Bio less than other Medical companies. The consensus rating score for Adicet Bio is 2.57 while the average consensus rating score for medical companies is 2.68. Learn more on how ACET compares to other companies.

Does Adicet Bio's stock price have much upside?

According to analysts, Adicet Bio's stock has a predicted upside of 308.35% based on their 12-month stock forecasts.

What analysts cover Adicet Bio?

Adicet Bio has been rated by HC Wainwright, and Wedbush in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:ACET) was last updated on 2/29/2024 by MarketBeat.com Staff